Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
Holding KVUE?
Track your performance easily
KVUE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.67 - $23.55
Previous Close$23.39
Volume15.23M
Average Volume (3M)17.37M
Market Cap
$44.80B
Enterprise Value$52.26B
Total Cash (Recent Filing)$1.01B
Total Debt (Recent Filing)$8.48B
Price to Earnings (P/E)40.0
Beta0.51
Next Earnings
Oct 24, 2024EPS Estimate
$0.28Last Dividend Ex-Date
Aug 14, 2024Dividend Yield3.44%
Share Statistics
EPS (TTM)0.58
Shares Outstanding1,915,167,356
10 Day Avg. Volume14,964,293
30 Day Avg. Volume17,371,044
Standard Deviation0.10
R-Squared0.32
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)4.41
Price to Sales (P/S)2.89
Price to Cash Flow (P/CF)25.50
P/FCF Ratio25.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.38
Enterprise Value/Gross Profit6.05
Enterprise Value/Ebitda32.26
Forecast
1Y Price Target
$22.00Price Target Upside-5.13% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Kenvue, Inc. News
PremiumThe Fly
Kenvue rises 12.0%
Bulls Say, Bears Say
Bulls Say
Capital AllocationKVUE is prioritizing its capital allocation with: investing in brands, returning cash to shareholders in dividends, deleveraging, and evaluating potential tuck-in acquisitions.
EarningsKVUE stock outperformed following earnings results, +15% as results beat expectations while KVUE reiterated 2024 guidance.
Financial PerformanceKVUE saw gains from supply chain efficiency, commodity pricing, and value realization, resulting in a better gross margin of 61.6%.
Bears Say
Consumption TrendsChallenged US consumption trends alongside weaker allergy demand and a soft start to the sun season.
Market ExpectationsThe buy side is already braced for weakness, noting that the 2Q EPS of $0.28 remains one-penny ahead of Street.
Market PerformanceProlonged weakness in US/China Skin Health & Beauty and challenging YTD comparisons in Self Care.
---
Ownership Overview
9.54% Insiders
40.68% Mutual Funds
40.39% Other Institutional Investors
9.40% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.67 and its highest was $23.55 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Currently, no data Available
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Oct 24, 2024 which is in 35 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Aug 06, 2024. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.276 by $0.044.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Overvalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Semiannually dividend of $0.2 which represents an annual dividend yield of 3.44%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is $0.28.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,915,167,400 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.32 in its last earnings report, beating expectations of $0.276. Following the earnings report the stock price went up 14.65%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Among the largest hedge funds holding Kenvue, Inc.’s share is Gates Capital Management, Inc.. It holds Kenvue, Inc.’s shares valued at 159M.
---
Kenvue, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.00 (-5.13% Downside)
$22.00 (-5.13% Downside)
Blogger Sentiment
Bullish
KVUE Sentiment 94%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 8.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.5%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.82%
12-Months-Change
Fundamentals
Return on Equity
10.55%
Trailing 12-Months
Asset Growth
-3.99%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc is a pure-play consumer health company. It is a global leader at the intersection of healthcare and consumer goods, with a portfolio of iconic brands, operating in some of the most attractive categories in consumer health. The consumer health portfolio includes self-care, skincare and beauty and essential personal care products.
---
KVUE Company Deck
---
KVUE Earnings Call
Q2 2024
0:00 / 0:00
---
KVUE Revenue Breakdown
41.77% Self Care
29.88% Essential Health
28.35% Skin Health and Beauty
---
KVUE Stock 12 Month Forecast
Average Price Target
$22.00
▼(-5.13% Downside)
Technical Analysis
Best Analysts Covering KVUE
1 Year
1 Year Success Rate
8/9 ratings generated profit
1 Year Average Return
+14.52%
reiterated a buy rating last month
Copying Andrea Faria Teixeira's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +14.52% per trade.
---